NASOPHARYNX CANCER
Clinical trials for NASOPHARYNX CANCER explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNX CANCER trials appear
Sign up with your email to follow new studies for NASOPHARYNX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and cetuximab, in 78 people with advanced head and neck cancer that had come back or spread. Participants were grouped based on whether they had tried these drugs before. The goal was to see if the combination could shri…
Matched conditions: NASOPHARYNX CANCER
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 17, 2026 08:05 UTC
-
New chemo cocktail shows promise for tough throat cancer
Disease control CompletedThis study tested a new combination of chemotherapy drugs (nab-paclitaxel, cisplatin, and fluorouracil) followed by standard radiation and chemo in 60 people with advanced nasopharyngeal cancer, a type of throat cancer common in southern China. The goal was to see if this approac…
Matched conditions: NASOPHARYNX CANCER
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 11, 2026 20:51 UTC